STOCK TITAN

Issuer AMLX (NASDAQ: AMLX) proposes sale of 10,250 RSU shares on 02/23/2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AMLX reports a proposed sale of Common stock tied to the vesting of Restricted Stock Units, totaling 10,250 shares with an anticipated action date of 02/23/2026. The filing also records that Gina Mazzariello sold 3,448 shares on 02/02/2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists a planned sale of vested RSUs and a recent smaller disposition.

The filing states 10,250 Common shares are to be sold associated with the vesting of Restricted Stock Units on 02/23/2026. This describes a scheduled disposal tied to vesting rather than an open‑market, discretionary purchase.

Cash‑flow treatment is not specified in the excerpt; subsequent filings or trade reports may show whether sales occur via brokered transactions. The earlier reported sale of 3,448 shares on 02/02/2026 is recorded as a past disposition by Gina Mazzariello.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does AMLX's Form 144 disclose about the RSU vesting?

The filing discloses a planned sale of 10,250 Common shares tied to RSU vesting on 02/23/2026. These shares are described as the result of the vesting of Restricted Stock Units, with the filing listing the sale method as issuer-related.

Who sold shares recently according to the AMLX excerpt?

Gina Mazzariello is listed as having sold 3,448 Common shares on 02/02/2026. That transaction appears under “Securities Sold During The Past 3 Months” in the provided excerpt.

Does the Form 144 excerpt state how the RSU-related shares will be sold?

The excerpt ties the 10,250 share sale to the vesting of Restricted Stock Units and labels the counterparty as Issuer. Specific distribution methods or broker details are not provided in the excerpt.

Are there outstanding share counts or other context numbers in the excerpt?

The excerpt includes numeric entries (for example 3419, 48352, 141274) and an address, but it does not explicitly label any of those as shares outstanding in the provided lines.

What is the effective date tied to the proposed sale in the AMLX excerpt?

The proposed sale tied to RSU vesting is dated 02/23/2026. That date is listed alongside the 10,250 share amount in the “Securities To Be Sold” section.
Amylyx Pharmaceuticals

NASDAQ:AMLX

AMLX Rankings

AMLX Latest News

AMLX Latest SEC Filings

AMLX Stock Data

1.53B
91.52M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE